We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
-15.83%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.76B
AUM Growth
-$3.06B
(-45%)
Cap. Flow
-$2.1B
Cap. Flow
% of AUM
-55.74%
Top 10 Holdings %
Top 10 Hldgs %
30.37%
Holding
139
New
24
Increased
31
Reduced
30
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GoDaddy
GDDY
|
+$74.9M |
| 2 |
Microchip Technology
MCHP
|
+$72.9M |
| 3 |
Blackrock
BLK
|
+$68.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$61.5M |
| 5 |
Align Technology
ALGN
|
+$59.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$172M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$161M |
| 3 |
AGN
Allergan plc
AGN
|
+$131M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$123M |
| 5 |
Pacira BioSciences
PCRX
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.45% |
| 2 | Technology | 16.06% |
| 3 | Financials | 5.24% |
| 4 | Communication Services | 3.47% |
| 5 | Consumer Discretionary | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNNA
76
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| $3.66M | 0.1% |
1,576,619
+308
| +0% | +$2.71K |
|
|
CBLK
77
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $3.1M | 0.08% |
231,286
| – | – |
|
78
Arcus Biosciences
RCUS
$3.55B
| $2.38M | 0.06% |
220,976
-502,858
| -69% | -$5.87M |
|
79
Zscaler
ZS
$24.5B
| $1.84M | 0.05% |
46,814
| – | – |
|
80
Ascendis Pharma A/S
ASND
$16B
| $1.72M | 0.05% |
+27,519
| New | +$1.73M |
|
81
StoneCo
STNE
$2.77B
| $1.59M | 0.04% |
+86,453
| New | +$2M |
|
|
MRNS
82
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.51M | 0.04% |
131,166
-312,358
| -70% | -$6.32M |
|
|
PLAN
83
DELISTED
Anaplan, Inc.
PLAN
| $891K | 0.02% |
+33,587
| New | +$830K |
|
|
DOCU
84
DocuSign
DOCU
$10.5B
| $769K | 0.02% |
19,199
| – | – |
|
85
Liberty Media Series C
FWONK
$24.6B
| $447K | 0.01% |
+15,043
| New | +$468K |
|
86
Neuronetics
STIM
$138M
| $444K | 0.01% |
+22,937
| New | +$503K |
|
87
Adobe
ADBE
$99.5B
| $242K | 0.01% |
+1,071
| New | +$259K |
|
|
ATVI
88
DELISTED
Activision Blizzard
ATVI
| $197K | 0.01% |
4,226
-386,108
| -99% | -$23.1M |
|
89
Agilent Technologies
A
$39.1B
| – | – |
-1,247,899
| Closed | -$88M |
|
90
Apple
AAPL
$4.54T
| – | – |
-1,126,512
| Closed | -$63.6M |
|
91
PUT
AMN Healthcare
AMN
$1.3B
| – | – |
-987,100
| Closed | -$54M |
|
|
AUTL
92
Autolus Therapeutics
AUTL
$397M
| – | – |
-219,628
| Closed | -$6.74M |
|
93
Boston Scientific
BSX
$69.5B
| – | – |
-1,907,622
| Closed | -$73.4M |
|
94
Cirrus Logic
CRUS
$6.53B
| – | – |
-1,125,349
| Closed | -$43.4M |
|
95
DexCom
DXCM
$32.2B
| – | – |
-1,221,216
| Closed | -$43.7M |
|
96
Electronic Arts
EA
$53B
| – | – |
-186,604
| Closed | -$22.5M |
|
|
EB
97
DELISTED
Eventbrite
EB
| – | – |
-58,441
| Closed | -$2.22M |
|
98
eBay
EBAY
$50.6B
| – | – |
-636,024
| Closed | -$21M |
|
99
Elanco Animal Health
ELAN
$13.2B
| – | – |
-811,700
| Closed | -$28.3M |
|
100
Guidewire Software
GWRE
$12.6B
| – | – |
-408,373
| Closed | -$41.3M |
|
Similar funds
DAM
MAM
LCM
DAM
KCM
CF
MIA
YL
PFM Health Sciences's Q4 2018 Portfolio in Review
As of Q4 2018, PFM Health Sciences held 139 positions worth $3.76B, down 45% from $6.83B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
PFM Health Sciences withdrew a net $2.1B in Q4 2018, closing 45 positions and reducing 30 holdings. Its most notable exit was Viatris, an estimated $172M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 50% a quarter earlier, followed by Technology and Financials.
Against the trend, PFM Health Sciences opened a new position in Microchip Technology worth $74.3M.
- PFM Health Sciences's largest Q4 2018 buy was Microchip Technology: 2,064,984 shares worth $74.3M.
- PFM Health Sciences added most to GoDaddy in Q4 2018, an estimated $74.9M increase.
- PFM Health Sciences's biggest Q4 2018 reduction was Pacira BioSciences, cutting an estimated $106M.
- PFM Health Sciences fully exited Viatris in Q4 2018, selling an estimated $172M.
- PFM Health Sciences's ten largest holdings make up 30% of its $3.76B portfolio in Q4 2018.
- PFM Health Sciences opened 24 new positions and closed 45 in Q4 2018.
- PFM Health Sciences's portfolio value fell 45% quarter-over-quarter to $3.76B.
Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.